NCT01376063

Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects

A Phase 1, Single-Center, One-Sequence, Open-Label Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Kyntra Bio · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The primary purpose of this study is to assess the effect of multiple doses of FG-4592 on the plasma pharmacokinetic of rosiglitazone in healthy adult subjects.

Conditions

• Healthy Adult Subjects

Interventions

Type	Name	Description
DRUG	FG-4592	FG-4592 on days 3,5,7,9 Rosiglitazone maleate on days 1 and 9

Timeline

• Start date: 2010-03-01
• Primary completion: 2010-05-01
• Completion: 2010-06-01
• First posted: 2011-06-20
• Last updated: 2011-06-20